Clinical Trial Results:
Randomized, multinational, multicenter, double-blind, placebo-controlled, two-arm parallel group trial of rimonabant 20 mg OD for reducing the risk of major cardiovascular events in abdominally obese patients with clustering risk factors
Summary
|
|
EudraCT number |
2005-002942-20 |
Trial protocol |
SE GB ES DE AT FI BE DK HU CZ IE PT GR IT |
Global completion date |
29 Apr 2009
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
05 Jun 2016
|
First version publication date |
05 Jun 2016
|
Other versions |
|
Summary report(s) |
EFC5826 |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.